This morning we woke up to the news that pharmaceutical company Activis has entered into a definitive agreement to acquire Allergan, the makers of Botox, Juvederm, and Voluma. With this transaction approved unanimously by both boards of directors, they are set to be a competitive global pharma company. “This acquisition creates the fastest growing and most dynamic growth pharmaceutical company in global healthcare, making us one of the world’s top 10 pharmaceutical companies,” said Brent Saunders, CEO and President of Activis.
Activis mission statement mirrors some of the most important values that we have admired in Allergan. Activis states that they are committed to high quality pharmaceutical products, a customer service focus and they have a robust department for research and development. This will lead to one of the worlds top global pharma companies once this acquisition is finalized.
Earlier in the year we were pleased to form a growing relationship with Galderma Laboratories when they added Dysport, Restylane, Restlyane Silk, and Perlane, to their roster of products. We are similarly looking forward to this new alignment with Activis. Both companies are huge players in the global pharmaceutical market bringing amazing opportunities on the horizon for all.